Abstract
Curative results in the treatment of esophageal carcinomas have been significantly improved neither by surgery nor by radiotherapy during the past 40 years. Thus the 5-year survival rate is below 10% in both surgically treated and primarily irradiated patients. Survival rates of between 10% and 20% can only be achieved in the subgroup of patients with resectable tumors. This means that surgery is the treatment of choice in cases with potential resectability and lack of metastases. However, only 10%–15% of patients treated surgically undergo potentially curative resection. In the in- operable patients the most effective component in palliative treatment is still radiotherapy. Furthermore, in some cases only radiotherapy offers a chance of cure.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fritz P, Schraube P, Oberle J, Wannenmacher M, Friedl P (1992) Perkutan-endokavitare Strahlenbehandlung der Ösophaguskarzinome. Strahlenther Onkol 168: 154–161
Hou BS, Xiong QB, Li DJ (1989) Thermo-chemo-radio-therapy of esophageal cancer. Cancer 64: 1777–1782
Hürter W, Reinbold F, Lorenz WJ (1991) A dipole antenna for interstitial microwave hyperthermia. IEEE Trans Microwave Theory Tech 39: 6
Isaev IG, Beibutov SM (1988) Strahlentherapie des Ösophaguskarzinoms mit dynamischer Dosisfraktionierung in Kombination mit Metronidazol und lokaler Hyper-thermie. Radiobiol Radiother 29: 5–9
Li DJ, Hou BS (1987) Preliminary report on the treatment of esophageal cancer by intraluminal microwave hyperthermia and chemotherapy. Cancer Treat Rep 71: 1013–1019
Li DJ, Wang CQ, Qin SL, Shao LF (1982) Intraluminal microwave hyperthermia in the combined treatment of esophageal cancer: a preliminary report of 103 patients. Natl Cancer Inst Monogr 61: 419–421
Mantravadi RVP, Lad T, Briele H, Liebner EJ (1982) Carcinoma of the esophagus: sites of failure. Int J Radiat Oncol Biol Phys 8: 1897–1901
Perez CA (1985) Non-small cell carcinoma of the lung: dosetime parameters. Cancer Treat Symp 2: 131
Poplin E, Fleming T, Leichmann L et al. (1987) Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG 8037). J Clin Oncol 5: 622–628
Sha YH, Li DJ, Qin SL et al. (1984) The combined treatment of esophageal cancer -a clinical pathological study of 42 cases. In: Overgaard JD (ed) Hyperthermic oncology. Taylor & Francis, London, pp 371–374
Sugimachi K, Matsuda H (1990) Experimental and clinical studies of hyperthermia for carcinoma of the esophagus. In: Gautherie M (ed) Interstitial, endocavitary and perfu-sional hyperthermia. Springer, New York Berlin Heidelberg, pp 59–76
Sugimachi K, Kai H, Matsufuji H et al. (1986) Histo-pathological evaluation of hyperthermo-chemo-radio-therapy for carcinoma of the esophagus. J Surg Oncol 32: 82–85
Wannenmacher M, Slanina J, Bruggmoser G, Nanko N (1986) Strahlentherapie des Ösophaguskarzinomes -Indi-kationen, Methodik und erzielbare Ergebnisse. Radiologe 26: 479–489
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fritz, P., Hürter, W., Schraube, P., Reinbold, F., Lorenz, W.J., Wannenmacher, M. (1993). Intracavitary Thermoradiotherapy for Esophageal Cancer. In: Seegenschmiedt, M.H., Sauer, R. (eds) Interstitial and Intracavitary Thermoradiotherapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84801-8_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-84801-8_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84803-2
Online ISBN: 978-3-642-84801-8
eBook Packages: Springer Book Archive